Shubham Pant Selected Research

Shubham Pant Research Topics

Disease

75	Neoplasms (Cancer) 05/2024 - 01/2008
19	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 06/2014
19	Adenocarcinoma 03/2024 - 01/2015
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2015
7	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2008
6	Endometrial Neoplasms (Endometrial Cancer) 05/2024 - 01/2018
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 10/2016
5	Fatigue 05/2024 - 11/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2018
5	Disease Progression 01/2023 - 07/2012
4	Melanoma (Melanoma, Malignant) 05/2024 - 01/2021
4	Microsatellite Instability 03/2021 - 01/2019
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 10/2018
3	Exanthema (Rash) 12/2023 - 01/2021
3	Diarrhea 12/2023 - 11/2020
3	Infections 12/2023 - 09/2022
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2023 - 06/2015
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023 - 01/2022
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 03/2016
3	Carcinoma (Carcinomatosis) 01/2023 - 11/2020
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2020
3	Nausea 10/2021 - 01/2021
2	Hyperbilirubinemia 05/2024 - 02/2020
2	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2020
2	Hypoxia (Hypoxemia) 12/2023 - 01/2021
2	Leiomyosarcoma 12/2023 - 03/2016
2	Mucositis 12/2023 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 09/2013
2	Fever (Fevers) 12/2023 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 09/2013
2	Cholangiocarcinoma 01/2023 - 01/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 04/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
2	Vomiting 10/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 10/2021 - 11/2019
2	Neutropenia 10/2021 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 11/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2019
2	Hypertension (High Blood Pressure) 11/2020 - 12/2016
2	Small Cell Carcinoma 11/2019 - 01/2016
1	Hypoalbuminemia 05/2024
1	Anemia 05/2024

Drug/Important Bio-Agent (IBA)

11	Gemcitabine FDA Link 10/2023 - 06/2014
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2014
7	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 04/2008
6	130-nm albumin-bound paclitaxelIBA 10/2023 - 01/2018
6	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2020
6	pembrolizumabIBA 03/2021 - 01/2019
5	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 06/2015
4	Bevacizumab (Avastin)FDA Link 12/2023 - 06/2014
4	Circulating Tumor DNAIBA 01/2023 - 01/2021
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 06/2015
3	Alkaline PhosphataseIBA 05/2024 - 11/2020
3	zanidatamabIBA 02/2024 - 12/2022
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2015
3	RamucirumabIBA 12/2023 - 11/2020
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2023 - 11/2020
3	sapanisertibIBA 12/2023 - 11/2020
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 10/2016
3	selinexorIBA 01/2023 - 10/2021
3	AntigensIBA 01/2023 - 01/2020
3	taxaneIBA 04/2021 - 04/2008
3	Cetuximab (Erbitux)FDA Link 01/2021 - 09/2013
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2020
3	pegilodecakinIBA 01/2021 - 11/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2020
3	folfirinoxIBA 10/2020 - 01/2020
2	spartalizumabIBA 05/2024 - 06/2022
2	human ERBB2 proteinIBA 05/2024 - 01/2019
2	olaparibIBA 12/2023 - 01/2020
2	Lipase (Acid Lipase)FDA Link 12/2023 - 12/2023
2	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 06/2016
2	trifluridine tipiracil drug combinationIBA 01/2023 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2022
2	PlatinumIBA 01/2023 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2016
2	LigandsIBA 01/2023 - 12/2020
2	Capecitabine (Xeloda)FDA Link 11/2022 - 01/2015
2	Topotecan (Hycamtin)FDA LinkGeneric 04/2022 - 10/2021
2	entrectinibIBA 03/2021 - 01/2020
2	larotrectinibIBA 03/2021 - 01/2020
2	LY3023414IBA 01/2021 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2008
2	EnzymesIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 11/2020 - 10/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 11/2018 - 10/2016
2	Aurora Kinase AIBA 01/2018 - 01/2018
2	MLN 8237IBA 01/2018 - 01/2018
2	Docetaxel (Taxotere)FDA Link 10/2016 - 04/2008
2	Ifosfamide FDA LinkGeneric 06/2015 - 09/2013
2	Taxoids (Taxanes)IBA 07/2012 - 04/2008
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2024

Therapy/Procedure

49	Therapeutics 02/2024 - 08/2007
16	Drug Therapy (Chemotherapy) 02/2024 - 02/2014
12	Immunotherapy 02/2024 - 01/2018
4	Pancreatectomy 03/2024 - 01/2020
3	Neoadjuvant Therapy 03/2024 - 12/2022
3	Investigational Therapies (Experimental Therapy) 02/2023 - 01/2021
2	Castration 01/2022 - 01/2021